nih-gov/www.ncbi.nlm.nih.gov/books/NBK531245/index.html?report=printable

142 lines
No EOL
17 KiB
XML

<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<!-- AppResources meta begin -->
<meta name="paf-app-resources" content="" />
<script type="text/javascript">var ncbi_startTime = new Date();</script>
<!-- AppResources meta end -->
<!-- TemplateResources meta begin -->
<meta name="paf_template" content="" />
<!-- TemplateResources meta end -->
<!-- Logger begin -->
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK531245" /><meta name="ncbi_domain" content="lactmed" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK531245/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
<!-- Logger end -->
<title>Epoetin Beta - Drugs and Lactation Database (LactMed®) - NCBI Bookshelf</title>
<!-- AppResources external_resources begin -->
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
<!-- AppResources external_resources end -->
<!-- Page meta begin -->
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="Drugs and Lactation Database (LactMed®) [Internet]" /><meta name="citation_title" content="Epoetin Beta" /><meta name="citation_publisher" content="National Institute of Child Health and Human Development" /><meta name="citation_date" content="2023/09/15" /><meta name="citation_pmid" content="30277694" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK531245/" /><meta name="citation_keywords" content="Mircera" /><meta name="citation_keywords" content="Pegzerepoetin alfa" /><meta name="citation_keywords" content="CERA" /><meta name="citation_keywords" content="CERA [WHO-DD]" /><meta name="citation_keywords" content="UNII-LR3UXN0193" /><meta name="citation_keywords" content="Pegzerepoetin alfa [WHO-DD]" /><meta name="citation_keywords" content="LR3UXN0193" /><meta name="citation_keywords" content="HSDB 8219" /><meta name="citation_keywords" content="Methoxy polyethylene glycol-epoetin beta" /><meta name="citation_keywords" content="Continuous erythropoietin receptor activator" /><meta name="citation_keywords" content="Methoxy polyethylene glycol-epoetinbeta [MART.]" /><meta name="citation_keywords" content="Methoxy polyethylene glycol-epoetinbeta [EMA EPAR]" /><meta name="citation_keywords" content="1-165-Erythropoietin (human), monamide with alpha-(3-carboxypropyl)-omega-methoxypoly(oxy-1,2-ethanediyl)" /><meta name="citation_keywords" content="677324-53-7" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Epoetin Beta" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Child Health and Human Development" /><meta name="DC.Date" content="2023/09/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK531245/" /><meta name="description" content="Methoxy polyethylene glycol-epoetin beta is a synthetic form of erythropoietin that slowly releases the active drug, epoetin beta (recombinant human erythropoietin). Erythropoietin is a normal component of human milk. The excretion of exogenous methoxy polyethylene glycol-epoetin beta in breastmilk has not been studied; although the similar drug epoetin alfa has been studied and is considered to be acceptable during breastfeeding. Since no information is available on its use during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant." /><meta name="og:title" content="Epoetin Beta" /><meta name="og:type" content="book" /><meta name="og:description" content="Methoxy polyethylene glycol-epoetin beta is a synthetic form of erythropoietin that slowly releases the active drug, epoetin beta (recombinant human erythropoietin). Erythropoietin is a normal component of human milk. The excretion of exogenous methoxy polyethylene glycol-epoetin beta in breastmilk has not been studied; although the similar drug epoetin alfa has been studied and is considered to be acceptable during breastfeeding. Since no information is available on its use during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK531245/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-lactmed-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/lactmed/LM1416/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK531245/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
<!-- Page meta end -->
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CEC077D812D6100000000010000C9.m_5" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
<body class="book-part">
<div class="grid no_max_width">
<div class="col twelve_col nomargin shadow">
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
<div class="sysmessages">
<noscript>
<p class="nojs">
<strong>Warning:</strong>
The NCBI web site requires JavaScript to function.
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
</p>
</noscript>
</div>
<!--/.sysmessage-->
<div class="wrap">
<div class="page">
<div class="top">
<div class="header">
</div>
<!--<component id="Page" label="headcontent"/>-->
</div>
<div class="content">
<!-- site messages -->
<div class="container content">
<div class="document">
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. </p></div></div></div>
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK531245_"><span class="title" itemprop="name">Epoetin Beta</span></h1><p class="small">Last Revision: <span itemprop="dateModified">September 15, 2023</span>.</p><p><em>Estimated reading time: 1 minute</em></p></div><div class="body-content whole_rhythm" itemprop="text"><p>CASRN: 677324-53-7</p><div id="LM1416.Drug_Levels_and_Effects"><h2 id="_LM1416_Drug_Levels_and_Effects_">Drug Levels and Effects</h2><div id="LM1416.Summary_of_Use_during_Lactation"><h3>Summary of Use during Lactation</h3><p>Methoxy polyethylene glycol-epoetin beta is a synthetic form of erythropoietin that slowly releases the active drug, epoetin beta (recombinant human erythropoietin). Erythropoietin is a normal component of human milk. The excretion of exogenous methoxy polyethylene glycol-epoetin beta in breastmilk has not been studied; although the similar drug epoetin alfa has been studied and is considered to be acceptable during breastfeeding. Since no information is available on its use during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.</p></div><div id="LM1416.Drug_Levels"><h3>Drug Levels</h3><p><i>Maternal Levels.</i> Relevant published information on exogenous administration of epoetin beta was not found as of the revision date. However, breastmilk normally contains erythropoietin. Erythropoietin concentrations in human milk are in the range of approximately 4 to 5 units/L in the first 1 to 2 months postpartum and increase to 20 to 40 units/L by the third month and to 100 to 150 units/L by 12 months.[<a class="bk_pop" href="#LM1416.REF.1">1</a>]</p><p><i>Infant Levels.</i> Relevant published information was not found as of the revision date.</p></div><div id="LM1416.Effects_in_Breastfed_Infants"><h3>Effects in Breastfed Infants</h3><p>Enhancement of gastrointestinal tract maturation has been proposed as a function of erythropoietin in breastmilk.[<a class="bk_pop" href="#LM1416.REF.1">1</a>,<a class="bk_pop" href="#LM1416.REF.2">2</a>]</p></div><div id="LM1416.Effects_on_Lactation_and_Breastmi"><h3>Effects on Lactation and Breastmilk</h3><p>In small studies, epoetin alfa administration decreased serum prolactin in patients with amyotrophic lateral sclerosis,[<a class="bk_pop" href="#LM1416.REF.3">3</a>] but had no effect in normal subjects or in patients with renal failure undergoing chronic ambulatory peritoneal dialysis.[<a class="bk_pop" href="#LM1416.REF.4">4</a>,<a class="bk_pop" href="#LM1416.REF.5">5</a>] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.</p></div><div id="LM1416.Alternate_Drugs_to_Consider"><h3>Alternate Drugs to Consider</h3><p>
<a href="/books/n/lactmed/LM496/">Epoetin Alfa</a>
</p></div><div id="LM1416.References"><h3>References</h3><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="LM1416.REF.1">Miller
M, Iliff
P, Stoltzfus
RJ, Humphrey
J. Breastmilk erythropoietin and mother-to-child HIV transmission through breastmilk.
Lancet
2002;360:1246-8.
[<a href="https://pubmed.ncbi.nlm.nih.gov/12401271" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12401271</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="LM1416.REF.2">Semba
RD, Juul
SE. Erythropoietin in human milk: Physiology and role in infant health.
J Hum Lact
2002;18:252-61.
[<a href="https://pubmed.ncbi.nlm.nih.gov/12192960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12192960</span></a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="LM1416.REF.3">Tokg&#x000f6;z
B, Utas
C, Dogukan
A, et al.
Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing CAPD.
Ren Fail
2002;24:315-23.
[<a href="https://pubmed.ncbi.nlm.nih.gov/12166698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12166698</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="LM1416.REF.4">Bernini
GP, Mariotti
F, Brogi
G, et al.
Effects of erythropoietin administration on prolactin secretion in normal subjects.
Nephron
1993;65:522-6.
[<a href="https://pubmed.ncbi.nlm.nih.gov/8302403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8302403</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="LM1416.REF.5">Markianos
M, Kosmidis
ML, Sfagos
C. Reductions in plasma prolactin during acute erythropoietin administration.
Neuro Endocrinol Lett
2006;27:355-8.
[<a href="https://pubmed.ncbi.nlm.nih.gov/16816832" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16816832</span></a>]</div></dd></dl></div></div><div id="LM1416.Substance_Identification"><h2 id="_LM1416_Substance_Identification_">Substance Identification</h2><div id="LM1416.Substance_Name"><h3>Substance Name</h3><p>Epoetin Beta</p></div><div id="LM1416.CAS_Registry_Number"><h3>CAS Registry Number</h3><p>677324-53-7</p></div><div id="LM1416.Drug_Class"><h3>Drug Class</h3><p>Breast Feeding</p><p>Lactation</p><p>Milk, Human</p><p>Colony-Stimulating Factors</p><p>Hematinics</p><p>Hematopoietic Cell Growth Factors</p></div></div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_top_margin"><p><b>Disclaimer: </b>Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.</p></p></div></dd></dl></div><div id="bk_toc_contnr"></div></div></div>
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a><p class="small"><b>Attribution Statement:</b> LactMed is a registered trademark of the U.S. Department of Health and Human Services.</p></div><div class="small"><span class="label">Bookshelf ID: NBK531245</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30277694" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30277694</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/lactmed/">Contents</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/lactmed/LM496/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/lactmed/epoprostenol/" title="Next page in this title">Next &gt;</a></div></div></div></div>
</div>
</div>
</div>
<div class="bottom">
<div id="NCBIFooter_dynamic">
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
<component id="Breadcrumbs" label="helpdesk"/>-->
</div>
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
</div>
</div>
<!--/.page-->
</div>
<!--/.wrap-->
</div><!-- /.twelve_col -->
</div>
<!-- /.grid -->
<span class="PAFAppResources"></span>
<!-- BESelector tab -->
<noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK531245&amp;ncbi_domain=lactmed&amp;ncbi_report=printable&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK531245/?report=printable&amp;ncbi_app=bookshelf" /></noscript>
<!-- usually for JS scripts at page bottom -->
<!--<component id="PageFixtures" label="styles"></component>-->
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
</html>